CAS 6004-24-6|Cetylpyridinium chloride monohydrate

Introduction:Basic information about CAS 6004-24-6|Cetylpyridinium chloride monohydrate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameCetylpyridinium chloride monohydrate
CAS Number6004-24-6Molecular Weight358.001
Density/Boiling Point/
Molecular FormulaC21H40ClNOMelting Point81-84 °C
MSDSChineseUSAFlash Point/
Symbol
GHS06, GHS09
Signal WordDanger

Names

Namecetylpyridinium chloride monohydrate
SynonymMore Synonyms

Cetylpyridinium chloride monohydrate BiologicalActivity

DescriptionCetylpyridinium chloride monohydrate is a cationic quaternary ammonium compound, used in some types of mouthwashes, toothpastes, throat and nasal sprays, is an antiseptic that kills bacteria and other microorganisms, effective in preventing dental plaque and reducing gingivitis.
Related CatalogSignaling Pathways >>Anti-infection >>BacterialResearch Areas >>Infection

Chemical & Physical Properties

Melting Point81-84 °C
Molecular FormulaC21H40ClNO
Molecular Weight358.001
Exact Mass357.279846
PSA13.11000
LogP3.39510
InChIKeyNFCRBQADEGXVDL-UHFFFAOYSA-M
SMILESCCCCCCCCCCCCCCCC[n+]1ccccc1.O.[Cl-]
StabilityStable. Combustible. Incompatible with strong oxidizing agents, acids, acid anhydrides, acid chlorides.

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UU5075000
CHEMICAL NAME :
Pyridinium, 1-hexadecyl-, chloride, monohydrate
CAS REGISTRY NUMBER :
6004-24-6
LAST UPDATED :
199603
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C21-H38-N.Cl.H2-O
MOLECULAR WEIGHT :
358.07
WISWESSER LINE NOTATION :
T6KJ A16 &G &QH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage)
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
400 mg/kg
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
5 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
5 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

Safety Information

Symbol
GHS06, GHS09
Signal WordDanger
Hazard StatementsH301-H315-H319-H330-H335-H410
Precautionary StatementsP260-P304 + P340 + P310-P305 + P351 + P338-P403 + P233
Personal Protective EquipmentEyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
Hazard CodesT+:Verytoxic;
Risk PhrasesR25;R26;R38
Safety PhrasesS28-S36/37-S45-S7/9-S61-S26
RIDADRUN 2811 6.1/PG 1
WGK Germany3
RTECSUU5075000
Packaging GroupI
Hazard Class6.1
HS Code2933399090

Customs

HS Code2933399090
Summary2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles57

More Articles
Exosomes: novel effectors of human platelet lysate activity.

Eur. Cell. Mater. 28 , 137-51; discussion 151, (2014)

Despite the popularity of platelet-rich plasma (PRP) and platelet lysate (PL) in orthopaedic practice, the mechanism of action and the effectiveness of these therapeutic tools are still controversial....

Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles.

Eur. J. Pharm. Biopharm. 88(1) , 40-7, (2014)

The aim of this study was to develop lipid nanoparticles to deliver genistein (GEN) to deeper skin layers. To do so, the impact of lipid dynamic behavior (nanoparticle flexibility) on stability, relea...

Effect of silver nanoparticles on human mesenchymal stem cell differentiation.

Beilstein J. Nanotechnol. 5 , 2058-69, (2014)

Silver nanoparticles (Ag-NP) are one of the fastest growing products in nano-medicine due to their enhanced antibacterial activity at the nanoscale level. In biomedicine, hundreds of products have bee...

Synonyms

Cetylpyridinum chloride
Cetylpyridinium chloride monohydrate
CETYLPYRIDINII CHLORIDUM
MFCD00149977
CPC MONOHYDRATE
EINECS 204-593-9
Pyridinium, 1-hexadecyl-, chloride, hydrate (1:1:1)
cetylpyridinium chloride
Chlorohexadecyl pyridine
Ceetylpyridiniumchloride
1-Hexadecylpyridin-1-ium chloride hydrate
Cetylpyridinium chloride hydrate
hexadecylpyridium chloride
cetyl pyridium chloride
1-Hexadecylpyridinium chloride hydrate (1:1:1)
Halset
N-CETYLPYRIDINIUM CHLORIDE MONOHYDRATE
Hexadecylpyridinium Chloride Monohydrate
Dobendan
Sprol
1-cetylpyridin-1-ium chloride hydrate
CPC
1-hexadecylpyridinium chloride monohydrate
N-hexadecylpyridinium chloride monohydrate
CPC hydrate
CETYL PYRIDIMUM CHLORIDE
CAS 253-52-1|Phthalazine
CAS 496-15-1|Indoline
Recommended......
TOP